Kenyan healthtech startup Ilara Health has announced a significant operational review and restructuring that is expected to lead to substantial job losses. The company, which provides financing for diagnostic equipment, pharmaceuticals, and digital software to primary care clinics, has initiated a 30-day consultation process with affected employees, in line with local labour laws.
In a statement, Ilara Health attributed the decision to challenging market conditions and financing dynamics, specifically citing a “reversal of funding commitments and delays in disbursements.” The company will now shift its focus to its most cash-generative business lines to ensure service continuity for its network of clinics and their patients.
“This is a difficult moment for our team, especially in light of recent strides we have made in the business,” said Emilian Popa, Founder and CEO of Ilara Health. “We know that any potential job losses have a real impact on people’s lives. Our colleagues are at the heart of Ilara, and we are committed to supporting them through this period.”
A Sudden Shift
The restructuring comes in sharp contrast to the company’s recent fundraising successes. Earlier this year, the U.S. International Development Finance Corporation (DFC) announced a $1 million loan to Ilara Health. This was part of a broader $4.2 million pre-Series A debt and equity round in 2024 that included investors like DOB Equity and the Philips Foundation.
At the time, the capital was intended to help Ilara Health expand its reach and improve the quality of care in a country where the public healthcare system is often overstretched. “In Kenya, quality of care, not access, is the issue. Our goal since launch has been to improve the standards of care,” Popa said earlier this year.
Founded in 2019, Ilara Health built its model on bridging a critical gap for the estimated 15,000 private primary care clinics in Kenya. It provides affordable access to essential tools, from portable ultrasound devices sourced via partners like Butterfly Network to practice management software offered at a monthly subscription of around $6.25. The software digitizes clinic operations, and the data collected was intended to support a future working capital loan product for clinic owners.
Since its launch, the company has partnered with over 3,000 clinics across 46 of Kenya’s 47 counties, which collectively serve more than 6 million patients annually.
Ilara Health’s situation reflects a difficult funding climate where venture-backed startups, particularly in emerging markets, are facing increased pressure from investors to demonstrate a clear path to profitability. The sudden reversal of committed funding hints at the volatility of the current market, forcing companies to make tough decisions to extend their runway.
Despite the cutbacks, the company’s leadership emphasized its commitment to its core mission. “We are also resolutely focused on service delivery through the Ilara Health network,” Popa stated. “Our priority remains, as ever, to underserved communities who need access to essential healthcare services in Kenya.”
The company’s future strategy will now concentrate on its most stable revenue streams as it navigates this challenging period.